| Vol. 11.19 – 17 May, 2023 |
| |
|
|
| Using in-depth integrated multi-omics, researchers dissected the host response dynamics during multiple disease phases to reveal the molecular and cellular landscapes in the blood. [Immunity] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Investigators compared the efficacy of three booster vaccines against Omicron BA.5 challenge in rhesus macaques: mRNA-1273, the Novavax ancestral spike protein vaccine, or Omicron BA.1 spike protein version. [Science Immunology] |
|
|
|
| Researchers tracked SARS-CoV-2 receptor binding domain-specific antibody responses up to six months following Omicron BA.1 breakthrough infection in six mRNA-vaccinated individuals. [Nature Communications] |
|
|
|
| Using a computational design strategy, investigators designed an affinity-enhanced ACE2 decoy, FLIF, that exhibited tight binding to SARS-CoV-2 delta and omicron variants. [Communications Biology] |
|
|
|
| Structural analysis of these monoclonal antibodies (mAbs) in complex with trimeric spike protein showed that all three mAbs bivalently bind spike with two mAbs targeting class 1 and one targeting a class 4 receptor binding domain epitope. [Structure] |
| MORE IMMUNOLOGY OF INFECTIOUS DISEASE |
|
|
|
| Researchers investigated the phenotypic, functional, and transcriptional profiles of CD4+ tissue-resident memory T cells in the small intestine responding to acute viral infection, revealing a shared gene expression program and chromatin accessibility profile with circulating TH1. [Science Immunology] |
|
|
|
| Scientists showed that human cytomegalovirus (HCMV) infection primed neighboring cells for both subsequent HCMV infections and secondary infections with herpes simplex virus 1 and influenza A. [Science Advances] |
|
|
|
| The authors demonstrated that human papillomavirus E5 was a negative regulator of anti-viral interferon response pathways, antigen processing, and antigen presentation. [Cell Reports] |
|
|
|
| Investigators used an adult Zika virus infection mouse model, Ifnar1−/−, to investigate the mechanisms underlying neuroinflammation and neuropathogenesis. [Journal of Virology] |
|
|
|
|
| Scientists summarize the most recently developed broad-spectrum fusion inhibitors, such as neutralizing antibodies, peptides, proteins, small-molecule compounds, and candidate vaccines targeting the conserved elements in the SARS-CoV-2 S2 subunit. [Signal Transduction And Targeted Therapy] |
|
|
|
|
| The World Health Organization (WHO) announced that mpox was no longer a public health emergency of international concern — but researchers fear that the decision will draw critical resources away from curbing the disease, which is still prevalent in regions including Africa. [Nature] |
|
|
|
|
| June 6 – 10, 2023 Keystone, Colorado, United States |
|
|
|
|
|
| Brown University – Providence, Rhode Island, United States |
|
|
|
| UMass Chan Medical School – Worcester, Massachusetts, United States |
|
|
|
| National Institutes of Health – Bethesda, Maryland, United States |
|
|
|
| Rutgers University – New Brunswick, New Jersey, United States |
|
|
|
| UMass Chan Medical School – Worcester, Massachusetts, United States |
|
|
|
|